Aptadir Therapeutics jobs, careers, and hiring context

Explore Aptadir Therapeutics careers and hiring status. Find jobs at Aptadir Therapeutics and official application links when roles are open. Funding stage: Seed. Headcount: 1-10. Aptadir Therapeutics is a Milan, Italy-based preclinical biotech developing a new class of RNA inhibitor therapeutics called DNMT-interacting RNAs (DiRs) that block aberrant DNA methylation to reactivate silenced genes. Its lead candidate, CAP1-FMR1, targets Fragile X Syndrome, with additional programs in myelodysplastic syndrome and other cancers and rare genetic disorders. The science originates from Beth Israel Deaconess Medical Center, Italy's CNR, and the Cancer Science Institute of Singapore.

This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.